tirzepatide with semaglutide vs. for Weight Loss Addressing the Weight Loss Injectable

Deoxycholic acid has been on the market for more than 13 years

Approximately 1 in 4 insured Americans report being denied coverage for GLP-1 medications for weight loss

If your BMI at the start of the therapy is below a certain threshold and you are not experiencing other risks or conditions, it may not be enough on its own to be eligible for the Bridge Program

Impact of Selected Glucagon-like Peptide-1 Receptor Agonists on Serum Lipids, Adipose Tissue, and Muscle Metabolism-A Narrative Review

Is maternal influenza or fever during pregnancy associated with autism or developmental delays

His contributions focused on the early-stage scientific and translational pipeline, including strain discovery, functional optimization, and multi-strain formulation design